Braidwell »

Avidity Biosciences Ord shares owned by Braidwell

Quarter-by-quarter ownership of Avidity Biosciences Ord (RNA) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Avidity Biosciences Ord

Tip: Access up to 7 years of quarterly data

All positions including Avidity Biosciences Ord held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avidity Biosciences Ord by Braidwell

Quarter filed Position value Share count Share price at filing
2025-09-30 $15M 332k 43.57

More positions owned by Braidwell

Guardant Health Debt 1.250% 2/1 (Principal)
Caris Life Sciences (CAI)
Novocure Note 11/0 (Principal)
Xenon Pharmaceuticals (XENE)
Cg Oncology (CGON)
Neurocrine Biosciences (NBIX)
Repligen Corp Note 1.000%12/1 (Principal)
Krystal Biotech (KRYS)
Nuvalent Inc-a (NUVL)
Neogenomics Note 0.250% 1/1 (Principal)
Soleno Therapeutics (SLNO)
Irhythm Technologies Note 1.500% 9/0 (Principal)
Edgewise Therapeutics (EWTX)
Ironwood Pharmaceuticals Note 1.500% 6/1 (Principal)
Inspire Med Sys (INSP)

View all positions for Braidwell

Top funds holding Avidity Biosciences Ord

FMR
Henderson Group
Vanguard Group
Rtw Investments
Wellington Management Company
BlackRock
RA Capital Management
venBio Select Advisor
State Street Corporation
Geode Capital Management
Polar Capital Holdings
Bellevue Group
Casdin Capital
Goldman Sachs Group
OrbiMed Advisors

View all funds holding Avidity Biosciences Ord